Johnson & Johnson and lawyers for patients with failed metal-on-metal hip implants have submitted a possible $2. 475 billion settlement of certain lawsuits involving recalled DePuy ASR hip replacement products.
Johnson & Johnson (J&J) is the corporate parent of DePuy Orthopaedics, the company that distributed the recalled DePuy ASR hip products. Under the proposed settlement agreement, J&J will pay about $2.475 billion in compensation to patients who were forced to have revision surgery to remove and replace the defective ASR hip implants.
The settlement plan anticipates about $2.475 billion in payments by J&J divided as follows:
- $2 billion to cover basic awards and
- $475 million to cover additional payments to patients who suffered more significant injuries, including two or more revision surgeries and/or severe complications.
In addition, J&J has agreed to pay all medical costs related to the revision surgeries.
The settlement plan has been submitted to U.S. District Court Judge David A. Katz.
You can contact our attorneys for a free consultation (click here now).
